Literature DB >> 24853650

Effects of electroconvulsive therapy and magnetic seizure therapy on acute memory retrieval.

Julia D Polster1, Sarah Kayser, Bettina H Bewernick, René Hurlemann, Thomas E Schlaepfer.   

Abstract

OBJECTIVES: Electroconvulsive therapy (ECT) is currently the most effective treatment for severe depression. However, it is frequently associated with negative cognitive side effects. Magnetic seizure therapy (MST) depicts an alternative, although experimental, convulsive treatment for major depression. Initial results suggest comparable antidepressant effects accompanied by a better side effect profile. However, no studies up to now have addressed acute retrieval disruption after MST in comparison to ECT. Therefore, we intended to broaden insight into the side effect profile of MST compared to ECT by examining the disruption of acute verbal memory processes after treatment.
METHODS: Twenty depressed patients were randomly assigned to either MST (10 patients) or ECT (10 patients) treatment. On 2 treatment days and 2 treatment-free days, the patients memorized words using a controlled learning paradigm derived from the Batchelder and Riefer storage retrieval model. Four hours after memorization, the patients were asked to retrieve words freely (delayed recall) and a second time with the help of an additional cue constructed out of a hypernymic category (cued recall). By comparing memory performance on treatment days to control days, treatment-induced memory disruption was evaluated.
RESULTS: After ECT, delayed recall was disturbed, whereas after MST, it was not. However, this difference in performance was no longer apparent upon cue application (cued recall).
CONCLUSIONS: This study demonstrates that ECT-induced acute memory disruption measured by delayed recall is absent after MST, confirming its superior side effect profile. We hope that confirming advantages of MST over ECT will improve therapy options for patients with severe depression.

Entities:  

Mesh:

Year:  2015        PMID: 24853650     DOI: 10.1097/YCT.0000000000000130

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  9 in total

Review 1.  An overview on clinical aspects in magnetic seizure therapy.

Authors:  Alice Engel; Sarah Kayser
Journal:  J Neural Transm (Vienna)       Date:  2016-06-23       Impact factor: 3.575

Review 2.  Magnetic Seizure Therapy for Unipolar and Bipolar Depression: A Systematic Review.

Authors:  Eric Cretaz; André R Brunoni; Beny Lafer
Journal:  Neural Plast       Date:  2015-05-13       Impact factor: 3.599

3.  Repetitive Transcranial Magnetic Stimulation for Depression: State of the Art.

Authors:  M S Reddy; M Starlin Vijay
Journal:  Indian J Psychol Med       Date:  2017 Jan-Feb

4.  Shorter recovery times and better cognitive function-A comparative pilot study of magnetic seizure therapy and electroconvulsive therapy in patients with depressive episodes.

Authors:  Junyan Zhang; Yanping Ren; Wei Jiang; Jiong Luo; Fang Yan; Yilang Tang; Xin Ma
Journal:  Brain Behav       Date:  2020-10-17       Impact factor: 2.708

5.  Magnetic Seizure Therapy Compared to Electroconvulsive Therapy for Schizophrenia: A Randomized Controlled Trial.

Authors:  Jiangling Jiang; Jin Li; Yuanhong Xu; Bin Zhang; Jianhua Sheng; Dengtang Liu; Wenzheng Wang; Fuzhong Yang; Xiaoyun Guo; Qingwei Li; Tianhong Zhang; Yingying Tang; Yuping Jia; Zafiris J Daskalakis; Jijun Wang; Chunbo Li
Journal:  Front Psychiatry       Date:  2021-11-25       Impact factor: 4.157

6.  Magnetic seizure therapy for treatment-resistant depression.

Authors:  Jiangling Jiang; Caidi Zhang; Chunbo Li; Zhimin Chen; Xinyi Cao; Hongyan Wang; Wei Li; Jijun Wang
Journal:  Cochrane Database Syst Rev       Date:  2021-06-16

Review 7.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Authors:  Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-10-24       Impact factor: 4.861

8.  Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot Study.

Authors:  Victor M Tang; Daniel M Blumberger; Shawn M McClintock; Tyler S Kaster; Tarek K Rajji; Jonathan Downar; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Front Psychiatry       Date:  2018-01-16       Impact factor: 4.157

9.  25 Hz Magnetic Seizure Therapy Is Feasible but Not Optimal for Chinese Patients With Schizophrenia: A Case Series.

Authors:  Jiangling Jiang; Qingwei Li; Jianhua Sheng; Fuzhong Yang; Xinyi Cao; Tianhong Zhang; Yuping Jia; Jijun Wang; Chunbo Li
Journal:  Front Psychiatry       Date:  2018-05-29       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.